StonvexLoading…
StonvexStonvexStonvexCore line items from ADTX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 | Q1 2025 2025-03-31 |
|---|---|---|---|---|
Revenue | $3.19K | $2.77K | $2.02K | $1.02K |
Operating Income | $-19.57M | $-14.90M | $-11.76M | $-5.61M |
Net Income | $-43.10M | $-37.01M | $-12.97M | $-5.71M |
EPS (Diluted) | $-1153.83 | $-1605.17 | $-9.22 | $-8.12 |
Total Assets | $16.52M | $11.80M | $32.69M | $31.22M |
Total Liabilities | $12.56M | $20.66M | $20.70M | $15.46M |
Cash & Equivalents | $3.20M | $163.04K | $323.68K | $476.42K |
Free Cash Flow OCF − CapEx | $-25.70M | Not available | Not available | Not available |
Shares Outstanding | 411.50K | 50.92K | 3.18M | 1.21M |